fromNature
3 days agoDaily briefing: Time to retire the Turing test?
The US Food and Drug Administration has approved a blood test to aid in the diagnosis of Alzheimer's disease - the second such test and the first cleared for use in primary-care settings, such as a doctor's office. The test measures Alzheimer's-related proteins to rule out the disease in people with cognitive decline. Last week, pharma company Roche announced that the test was correctly able to rule out Alzheimer's 97.9% of the time.
Medicine